CEF19, Epstein-Barr Virus latent NA-3A (458-466)
Product Specifications
UNSPSC Description
CEF19, Epstein-Barr Virus latent NA-3A (458-466) is a single peptide epitope, YPLHEQHGM, representing residues 458-466 of the type 1 Epstein-Barr Virus (EBV) nuclear antigen 3A protein (B95.8 strain). CEF19, Epstein-Barr Virus latent NA-3A (458-466) can significantly affect cytotoxic T-lymphocyte (CTL) recognition[1].
Target Antigen
EBV
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cef19-epstein-barr-virus-latent-na-3a-458-466.html
Solubility
H2O
Smiles
CSCC[C@@H](C(O)=O)NC(CNC([C@H](CC1=CNC=N1)NC([C@H](CCC(N)=O)NC([C@H](CCC(O)=O)NC([C@H](CC2=CNC=N2)NC([C@H](CC(C)C)NC([C@H]3N(C([C@H](CC4=CC=C(O)C=C4)N)=O)CCC3)=O)=O)=O)=O)=O)=O)=O
Molecular Weight
1111.23
References & Citations
[1]Lee SP, et al. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population. Eur J Immunol. 1995 Jan;25(1):102-10.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P1920/CEF19-Epstein-Barr-Virus-latent-NA-3A-458-466-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P1920/
Clinical Information
No Development Reported
CAS Number
157876-41-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items